Upadacitinib has recently been approved for treating Crohn's disease (CD). Here, we report on the effectiveness and safety of upadacitinib in a cohort of patients with diffcult-to-treat CD being cared for at clinical centers across Italy.

Bezzio, C., Franchellucci, G., Savarino, E. V., Mastronardi, M., Caprioli, F. A., Bodini, G., Variola, A., Scaldaferri, F., Furfaro, F., Calabrese, E., Principi, M. B., Biscaglia, G., Marzo, M., Michielan, A., Cavalli, C., Aratari, A., Campigotto, M., Ceccarelli, L., Cappello, M., Saibeni, S., Balestrieri, P., Soriano, A., Casini, V., Bertani, L., Barberio, B., Conforti, F. S., Danese, S., Armuzzi, A., Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease, <<CROHN’S & COLITIS 360>>, 2024; 6 (4): N/A-N/A. [doi:10.1093/crocol/otae060] [https://hdl.handle.net/10807/312372]

Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease

Scaldaferri, Franco;Soriano, Alessandra;Danese, Silvio;Armuzzi, Alessandro
2024

Abstract

Upadacitinib has recently been approved for treating Crohn's disease (CD). Here, we report on the effectiveness and safety of upadacitinib in a cohort of patients with diffcult-to-treat CD being cared for at clinical centers across Italy.
2024
Inglese
Bezzio, C., Franchellucci, G., Savarino, E. V., Mastronardi, M., Caprioli, F. A., Bodini, G., Variola, A., Scaldaferri, F., Furfaro, F., Calabrese, E., Principi, M. B., Biscaglia, G., Marzo, M., Michielan, A., Cavalli, C., Aratari, A., Campigotto, M., Ceccarelli, L., Cappello, M., Saibeni, S., Balestrieri, P., Soriano, A., Casini, V., Bertani, L., Barberio, B., Conforti, F. S., Danese, S., Armuzzi, A., Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease, <<CROHN’S & COLITIS 360>>, 2024; 6 (4): N/A-N/A. [doi:10.1093/crocol/otae060] [https://hdl.handle.net/10807/312372]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/312372
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 4
social impact